SecBot SecBot

SRZNW

Surrozen, Inc.
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001824893 Biotech & Drug Discovery
—
Market cap
$17.4K
Nano cap
1 year
+115.1%
from $13.73 · Oct 28
30 days
−0.4%
from $29.64
52-week range
$11.80–34.13
−13% from high · low Nov 10
Avg volume 20D
632.8K
Sep 30 spike 1.66M
Short interest
8.7K
≈0.1% of shares · −13.8%
Days to cover
2.5
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BEARISH 3 reports · latest
Balance 1 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/3
Strongest NEUTRAL Surrozen reported Q1 2026 revenue of $5.0M, beating consensus estimate of $4.0M, driven by a $5M milestone…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 0 trimmed or exited.

  • Short sellersSTEADY

    Short interest −13.8% to 8.7K shares. 2.5 days to cover, ≈0.1% of shares.

  • TrendUPTREND

    23% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
Clear Street Group Inc.DOUBLED300$5.00
WOLVERINE ASSET MANAGEMENT LLCADD3,085$49.00
UBS Group AGADD2,701$43.00
UBS Group AGTRIM1,440$26.00
Hudson Bay Capital Management LPNEAR_EXIT20,718$213.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 10, 2026
Listing
Delisted: SRZNW — removed from the Nasdaq symbol directory
Surrozen, Inc. - Warrant

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$373.8K
Next Q———$373.8K
Current FY———$10.7M
Next FY———$1.5M

Short side

FINRA· Jul 31, 2026
8,662
shares short
-13.8%
vs prior settlement
2.5
days to cover
≈0.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 10, 2026 Listing status
Delisted: SRZNW — removed from the Nasdaq symbol directory
Surrozen, Inc. - Warrant
Jun 30, 2026 Inst.
Clear Street Group Inc. — DOUBLED
300 shares ($5.00)
May 6, 2026 SEC
Surrozen reported Q1 2026 revenue of $5.0M, beating consensus estimate of $4.0M, driven by a $5M milestone payment…
8-K — Impact 4/10
Apr 1, 2026 SEC
This DEFA14A filing is a definitive proxy statement for Surrozen, Inc., filed by the registrant. It contains standard…
DEFA14A — Impact 3/10
Mar 31, 2026 SEC
Surrozen, Inc.'s S-3 shelf registration has become effective, allowing the company to issue up to $200 million in…
EFFECT — Impact 7/10
Mar 31, 2026 Inst.
WOLVERINE ASSET MANAGEMENT LLC — ADD
3,085 shares ($49.00)

SecBot reports

3 filings · 0 bullish · 1 bearish · 2 neutral
All SRZNW filing & press-release reports (3)